Gynecare Prolift Device Named in Ethicon Lawsuit Filed this November in Texas Federal Court
A woman from southeast Texas has filed an Ethicon lawsuit against the Johnson & Johnson subsidiary, alleging the company’s device caused her to suffer bleeding, incontinence, dyspareunia and other side effects.
The plaintiff in this case, filed on Nov. 30 in the Eastern District of Texas, Texarkana Division, is Carolyn S. Turner, who received Ethicon’s Gynecare Prolift device to treat her pelvic organ prolapse (POP).
Turner was not the only woman allegedly victimized by this particular product. It was discovered last August, in the company’s Answer to the First Amended Master Complaint in the federal Ethicon transvaginal mesh multidistrict litigation (“MDL”) underway in the Southern District of West Virginia, that several other Ethicon lawsuits have been filed over the Gynecare Prolift device.
Other products at the center of Ethicon lawsuits include, but are not limited to: Prolene Mesh/Prolene Soft Mesh, TVT Abbrevo, and TVT Exact, TVT-SECUR, TVT-Obturator, Prolift + M as well as Prosima vaginal mesh devices. These devices were all named in the federal multidistrict litigation (MDL) based in the U.S. District Court, Southern District of West Virginia. (In re:Ethicon, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2327).
Last June, the company announced that it would be discontinuing four of its transvaginal mesh products, including the one included in Ms. Turner’s Ethicon lawsuit. As of that date, the company asked the U.S. Food and Drug Administration (FDA) for 120 days to stop selling the Gynecare Prolift Pelvic Floor Repair System, the Gynecare Prolift + M Pelvic Floor System, the Gynecare TVT Secur System and the Gynecare Prosima Pelvic Floor Repair System.
Other transvaginal mesh manufacturers are also preparing to defend their products in federal and state courts throughout the U.S. Federal MDL’s have been created to oversee lawsuits filed against American Medical Systems, Boston Scientific Corp, and C.R. Bard Inc.